跳至主要内容
临床试验/CTRI/2024/06/068514
CTRI/2024/06/068514尚未招募4 期

A post market clinical follow up prospective study to evaluate safety and performance of Sodium Hyaluronate Ophthalmic Solution - NI

Kilitch Healthcare India Ltd.0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • Subjects who are able to give voluntary, written informed consent to participate in this study.
  • Subjects who experience eye dryness, eye soreness/ burning, irritative sensation and discomfort
  • of eyes due to the continuous use of computer/ TV/ exposed pollution/ dry environment.

排除标准

  • Anyone with known allergic reaction to Sodium Hyaluronate Ophthalmic Solution.
  • Subjects with existing eye infection.
  • History of ocular surgery. History or active signs of severe or serious ocular conditions such as
  • inflammatory corneal ulcers, recurrent erosions, and uveitis at any time.
  • Patients participating in any another clinical trial during study.

研究者

发起方
Kilitch Healthcare India Ltd.

相似试验